share_log

Moderna | 4: Statement of changes in beneficial ownership of securities-Director AFEYAN NOUBAR

SEC announcement ·  Mar 16 07:02
Summary by Futu AI
Noubar Afeyan, associated with Moderna, Inc. [MRNA], completed a sale of 15,000 shares of common stock on March 13, 2024. The transactions were executed in the open market with prices ranging from $106.60 to $112.44 per share, resulting in a total market value of approximately $1.63 million. Following these transactions, Afeyan directly holds 2,131,931 shares of Moderna. Additionally, indirect holdings through Flagship Ventures Fund IV, L.P., Flagship Ventures Fund IV-Rx, L.P., and Flagship Pioneering, Inc. total 9,666,038 shares.
Noubar Afeyan, associated with Moderna, Inc. [MRNA], completed a sale of 15,000 shares of common stock on March 13, 2024. The transactions were executed in the open market with prices ranging from $106.60 to $112.44 per share, resulting in a total market value of approximately $1.63 million. Following these transactions, Afeyan directly holds 2,131,931 shares of Moderna. Additionally, indirect holdings through Flagship Ventures Fund IV, L.P., Flagship Ventures Fund IV-Rx, L.P., and Flagship Pioneering, Inc. total 9,666,038 shares.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.